Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Marine fungi contain promising anti-cancer compounds

28.10.2015

A Kiel-based research team has identified fungi genes that can develop anti-cancer compounds

To date, the ocean is one of our planet's least researched habitats. Researchers suspect that the seas and oceans hold an enormous knowledge potential and are therefore searching for new substances to treat diseases here.


Colonies of Scopulariopsis brevicaulis after roughly seven days of cultivation.

Photo: Linda Paun

In the EU "Marine Fungi" project, international scientists have now systematically looked for such substances specifically in fungi from the sea, with help from Kiel University and the GEOMAR Helmholtz Centre for Ocean Research Kiel.

A particularly promising finding is the identification of the genes of one of these fungi, which are responsible for the formation of two anti-cancer compounds - so-called cyclic peptides. A research team headed by Professor Frank Kempken, Head of the Department of Genetics and Molecular Biology in Botany at Kiel University, has now published these new findings in the current edition of PLOS One.

They studied a strain of Scopulariopsis brevicaulis, isolated from a marine sponge found in the Mediterranean Sea. Previous research has shown that the fungus can form the cyclic peptides scopularides A and B, which can inhibit the growth of pancreatic and colon tumour cells. Cyclic peptides have been at the centre of the search for medical substances for a while now.

A whole series of these proteins, formed by bacteria and fungi, amongst other things, have already proven themselves in various aspects of human therapy. Certain antibiotics such as Penicillin also belong to this group, for example.

Until now, however, it was not known which genes in the fungus are responsible for forming anti-cancer compounds. Using genome analysis, the researchers in Kiel were now able to identify NRPS 1 and PKS 2 from the roughly 16,000 eligible genes from the fungus. This gene pair forms the scopularides A and B. This makes it possible to synthetically produce the peptides and alter them in terms of ideal effectiveness.

"Fungi are capable of producing a wide range of different substances, depending on the external conditions. Our challenge lies in recognising the right circumstances for forming a possible compound as well as the genes involved. We have managed to do this, in this case, by identifying the genetic origin of the potential anti-cancer peptides", says Kempken on the importance of these research findings.

The researchers received the fungi cultures that they studied from the collection of the former Kiel Center for Marine Natural Products at GEOMAR (KiWiZ, now the GEOMAR-Biotech), which also deals with the search for marine agents. Professor Johannes F. Imhoff discovered the fungus during a microbiome analysis of the Tethya aurantium sponge. The sponge seemed to provide a setting in its middle that would enable the fungus to survive in the marine environment.

Kempken's research team then sequenced the genome from Scopulariopsis brevicaulis using three different methods. "When identifying the genes, it was helpful that fungi form so-called gene clusters. Genes that have the same function are close together in these organisms", says Dr Abhishek Kumar, former post-doctoral researcher in the Department of Genetics and Molecular Biology in Botany at Kiel University and current scientist at the DKFZ German Cancer Research Center in Heidelberg. The compounds from the marine fungus were able to inhibit the growth of certain pancreatic and colon tumour cells in a cell culture. Further intensive research is necessary, however, in order to discover whether the substances are suitable for human therapies.

Original publication:
Abhishek Kumar, Bernard Henrissat, Mikko Arvas, Muhammad Fahad Syed, Nils Thieme, J. Philipp Benz, Jens Laurids Sørensen, Eric Record, Stefanie Pöggeler, Frank Kempken (2015): De Novo Assembly and Genome Analyses of the Marine-Derived Scopulariopsis brevicaulis Strain LF580 Unravels Life-Style Traits and Anticancerous Scopularide Biosynthetic Gene Cluster, PLOS Biology.
Link: http://dx.doi.org/10.1371/journal.pone.0140398

Contact:
Prof. Frank Kempken
Abteilung Genetische Botanik und Molekularbiologie
Botanisches Institut und Botanischer Garten, CAU Kiel
Tel.: +49 (0)431/-880-4274
E-mail: fkempken@bot.uni-kiel.de

More information:
Department of Genetics and Molecular Biology in Botany
Botanical Institute and Botanical Gardens, Kiel University
http://www.uni-kiel.de/Botanik/Kempken/fbkem.shtml

Research focus “Kiel Life Science”, Kiel University
http://www.kls.uni-kiel.de

EU Cooperation project “Marine Fungi”:
https://www.marinefungi.eu/de

Dr. Boris Pawlowski | Christian-Albrechts-Universität zu Kiel

More articles from Life Sciences:

nachricht Fish recognize their prey by electric colors
13.11.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht The dawn of a new era for genebanks - molecular characterisation of an entire genebank collection
13.11.2018 | Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

Im Focus: Coping with errors in the quantum age

Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly

The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

The dawn of a new era for genebanks - molecular characterisation of an entire genebank collection

13.11.2018 | Life Sciences

Fish recognize their prey by electric colors

13.11.2018 | Life Sciences

Ultrasound Connects

13.11.2018 | Awards Funding

VideoLinks
Science & Research
Overview of more VideoLinks >>>